ARX788 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)
Phase 2 · HER2 Positive Metastatic Breast Cancer |
Ambrx, Inc. | ARX788 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|